Correspondence 0001493152-24-031320 from IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC.
Date: Aug. 12, 2024 · CIK: 0001834105 · Accession: 0001493152-24-031320

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275062

Date

Aug. 12, 2024

Author

Chief

Form

CORRESP

Company

IMPACT BIOMEDICAL INC.

Letter

Impact BioMedical Inc.

Broadfield Blvd., Suite 130

Houston, TX 77084

Tel: (585) 325-3610

August 12, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F. Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

Re: Re: Impact BioMedical Inc.

Registration Statement on Form S-1

File No. 333-275062

Withdrawal Request for Acceleration

Ladies and Gentlemen:

We hereby request the withdrawal of our request for acceleration, dated August 8, 2024, of the effective date of the Registration Statement on Form S-1, as amended (File No. 333-275062) that was requested to become effective at 4:00 p.m. Eastern Time, on August 12, 2024, or as soon thereafter as practicable. We hereby respectfully withdraw this acceleration request at this time.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia Ross Ference Carmel LLP, attention: Darrin M. Ocasio, Esq. at (917) 848-6325.

Very
truly yours,
IMPACT
BIOMEDICAL INC.

Show Raw Text

CORRESP
1
filename1.htm

Impact
BioMedical Inc.

1400
Broadfield Blvd., Suite 130

Houston,
TX 77084

Tel:
(585) 325-3610

    August
    12, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F. Street, N.E.

Washington,
D.C. 20549

Attention:
Daniel Crawford

    Re:
    Re:
                                            Impact BioMedical Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-275062

    Withdrawal
    Request for Acceleration

Ladies
and Gentlemen:

We
hereby request the withdrawal of our request for acceleration, dated August 8, 2024, of the effective date of the Registration Statement
on Form S-1, as amended (File No. 333-275062) that was requested to become effective at 4:00 p.m. Eastern Time, on August 12, 2024, or
as soon thereafter as practicable. We hereby respectfully withdraw this acceleration request at this time.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia
Ross Ference Carmel LLP, attention: Darrin M. Ocasio, Esq. at (917) 848-6325.

    Very
    truly yours,

    IMPACT
    BIOMEDICAL INC.

    By:
    /s/
    Frank D. Heuszel

    Frank
    D. Heuszel

    Chief
    Executive Officer

SecProbe.io